CBS – Chemistry for Biological Systems
BioISI Digest | Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
Miquéias Lopes-Pacheco published a review paper with data from clinical trials from patients with Cystic Fibrosis (CF) using a combination of three drugs, showing a significant decrease in disease symptoms like pulmonary and gastrointestinal manifestations as well as in pancreatic insufficiency. Find out how can this publication can give useful insights to the CF research field.
Bio[r]SciDE – Science Days and Ephemeris | World Autism Awareness Day
April 2 marks the World Autism Awareness Day. Today we want to share with you how BioISI researchers work to shape future and potential early diagnostic tools and life quality improvement strategies so that autistic people can fully live their lives and fulfill themselves.
Three former MSc students were admitted as experts into the Portuguese Scientific police
Last March 15, at the Judicial Police headquarters, in Lisbon, three former BioISI MSc students supervised by Helena Gaspar were admitted as experts into the Portuguese Scientific police.
BioISI Digest | Grapevine-Associated Lipid Signalling Is Specifically Activated in an Rpv3 Background in Response to an Aggressive P. viticola Pathovar
A recent paper, first-authored by Gonçalo Laureano and headed by Andreia Figueiredo, presents a study using a Plasmopara viticola strain capable of supress the defence mechanisms conferred by a specific defence gene, the Rpv3, in grapevine. Read the BioISI Digest below to know more.
Bio[r]SciDE – Science Days and Ephemeris | International Women’s Day
On this International Women's Day, we are challenged to embrace equity. Ciência Viva recognizes several Portuguese women devoted to Science in a new edition of the book “Women in Science”, which includes the portrait of 101 female researchers in different scientific fields. Get to know below the testimonials of three BioISI female researchers who have been recognized in this book.
Carlos Farinha has been awarded by Emily’s Entourage to develop a novel approach to potentially treat Nonsense Mutations of Cystic Fibrosis
Carlos Farinha has been awarded 220 thousand USD by Emily’s Entourage to support research on restoring CFTR protein function in people with Cystic Fibrosis bearing nonsense mutations.